Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland
Benedetta Terziroli Beretta‐Piccoli(Ente Ospedaliero Cantonale), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Carl Oneta(Kantonsspital Winterthur), Marco Carbone(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Emiliano Giostra(University Hospital of Geneva), Felix Stickel(University Hospital of Zurich), Beat Helbling, Guido Stirnimann(University of Bern), Carolina Kalid-de Bakker(University Hospital of Basel), Pietro Invernizzi(Azienda Ospedaliera San Gerardo), Roxane Hessler(Centre Hospitalier Universitaire Vaudois), David Semela(Kantonsspital St. Gallen), Magdalena Filipowicz Sinnreich(University of Basel), Andreas Cerny(Epatocentro Ticino), Adriana Baserga(Epatocentro Ticino), Florian Bihl(Ente Ospedaliero Cantonale)
Cited by 20
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484